Aspirus offers Clinical Trials for Cancer Patients

Aspirus believes that patients come first. Because our patients are our number one priority, we are committed to participating in clinical trials that offer hope when other medical interventions have been inadequate, intolerable, or viable options don’t currently exist.

This month is National Cancer Research Month. Aspirus continues to look for ways they can further cancer treatment by contributing to cancer research and offering patients advanced medical treatment through clinical trials that are suitable for each patient.

Aspirus is part of an organization called CROWN, The Cancer Research of Wisconsin and Northern Michigan Consortium. A collaboration of three of Wisconsin’s largest cancer treatment programs that provide medical research for clinical trials. Through CROWN, more than 2,000 people have been successfully enrolled.

“We believe that we should give our patients therapies that are better than the standard of care”, says Dr. Andrew Huang, Aspirus Radiation Oncologist and Aspirus CROWN Jr. Principal Investigator. “Not only do our patients get the chance to get the future standard of care 5-10 years early, but their participation changes medicine for the better.”

All clinical trials go through extensive research and each patient is closely observed by a research nurse – who provides concierge-type nursing. Patients can rest assured knowing that there is always someone who can answer their questions.

Clinical trials focus on new cancer treatments, controlling cancer symptoms, cancer screenings, preventing and monitoring cancer and evaluating how cancer care is delivered.

Clinical trials are currently being offered at Aspirus Wausau, Aspirus Riverview, Aspirus Langlade and Aspirus Medford Cancer Centers. Aspirus Stevens Point Cancer Care will be offering clinical trials in the future.

For more information about Aspirus Clinic Trials visit www.aspirus.org/clinical- trials.